ELIXIRGEN THERAPEUTICS Trademark

Trademark Overview


On Wednesday, December 1, 2021, a trademark application was filed for ELIXIRGEN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELIXIRGEN THERAPEUTICS trademark a serial number of 97150514. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Friday, August 2, 2024. This trademark is owned by Elixirgen Therapeutics, Inc.. The ELIXIRGEN THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical drugs for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for medicinal purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; preparations of organisms for medical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases

Research and development of vaccines and medicines; testing of pharmaceuticals; research in the field of pharmaceuticals; testing, inspection, research, or development of pharmaceutical preparations for gene therapy
elixirgen therapeutics

General Information


Serial Number97150514
Word MarkELIXIRGEN THERAPEUTICS
Filing DateWednesday, December 1, 2021
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateFriday, August 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Description of MarkThe mark consists of the word "elixirgen" in small case letters with the portion "elixir" being in dark shade and the portion "gen" being in lighter shade; the word "THERAPEUTICS" in dark shade capital letters appearing in smaller font than, directly under, and of the same total length as, the "elixir" portion; and, to the left of both words, a three-lobed, intertwined infinity loop appears in dark shade, medium shade, and white.
Goods and ServicesPharmaceutical drugs for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for medicinal purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; preparations of organisms for medical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development of vaccines and medicines; testing of pharmaceuticals; research in the field of pharmaceuticals; testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code005
First Use Anywhere DateThursday, July 6, 2023
First Use In Commerce DateThursday, July 6, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code042
First Use Anywhere DateSaturday, October 15, 2022
First Use In Commerce DateSaturday, October 15, 2022

Trademark Owner History


Party NameElixirgen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Party NameElixirgen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Trademark Events


Event DateEvent Description
Saturday, December 4, 2021NEW APPLICATION ENTERED
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 7, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, September 10, 2022ASSIGNED TO EXAMINER
Monday, September 19, 2022NON-FINAL ACTION WRITTEN
Monday, September 19, 2022NON-FINAL ACTION E-MAILED
Monday, September 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 22, 2024DIVISIONAL REQUEST RECEIVED
Friday, March 22, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, March 22, 2024USE AMENDMENT FILED
Friday, March 22, 2024TEAS REQUEST TO DIVIDE RECEIVED
Friday, April 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 12, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, August 2, 2024SU - NON-FINAL ACTION - WRITTEN
Friday, August 2, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 4, 2024DIVISIONAL PROCESSING COMPLETE
Wednesday, September 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED